3.66
Lakewood Amedex Biotherapeutics Inc stock is traded at $3.66, with a volume of 514.46K.
It is down -49.25% in the last 24 hours and up +0.00% over the past month.
Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.
See More
Previous Close:
$7.35
Open:
$5.75
24h Volume:
514.46K
Relative Volume:
5.96
Market Cap:
$51.31M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
Lakewood Amedex Biotherapeutics Inc Stock (LABT) Company Profile
Name
Lakewood Amedex Biotherapeutics Inc
Sector
Industry
Phone
-
Address
-
Compare LABT vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
LABT
Lakewood Amedex Biotherapeutics Inc
|
3.66 | 103.04M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.01 | 109.45B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
744.44 | 79.46B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
783.74 | 48.52B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.51 | 40.77B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
298.90 | 33.39B | 5.36B | 287.73M | 924.18M | 2.5229 |
Lakewood Amedex Biotherapeutics Inc Stock (LABT) Financials Data
There is no financial data for Lakewood Amedex Biotherapeutics Inc (LABT). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):